Home › Funds › Parkman Healthcare Partners LLC › DXCM
Parkman Healthcare Partners LLC position in DXCM
DEXCOM INC · Health Care
Parkman Healthcare Partners LLC reported holding 437,034 shares of DXCM (DEXCOM INC) in its Q3 2026 13F filing — a position valued at US$37.7M, representing 3.40% of its reported portfolio and ranking #5 among its reported holdings. Parkman Healthcare Partners LLC has disclosed DXCM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's DXCM position evolved
Parkman Healthcare Partners LLC first disclosed a stake in DXCM in Q3 2023 at 265,518 shares (US$24.8M). The position peaked in Q1 2026 at 689,822 shares, worth US$43.3M. Across 13 filings, Parkman Healthcare Partners LLC increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 437,034 shares valued at US$37.7M — a reduction of -97,733 shares quarter over quarter.. Notable position changes include a 66% increase in Q1 2025 (shares rose 23% over the following quarter), a 73% increase in Q2 2025 (shares fell 20% over the following quarter), a 242% increase in Q4 2025 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 265.52K | $24.77M | New |
| Q4 2023 | 225.62K | $28.00M | Reduce |
| Q1 2024 | 171.66K | $23.81M | Reduce |
| Q2 2024 | 156.85K | $17.78M | Reduce |
| Q3 2024 | 70.59K | $4.73M | Reduce |
| Q4 2024 | 78.55K | $6.11M | Add |
| Q1 2025 | 130.37K | $8.90M | Add |
| Q2 2025 | 225.88K | $19.72M | Add |
| Q3 2025 | 171.63K | $11.55M | Reduce |
| Q4 2025 | 587.48K | $38.99M | Add |
| Q1 2026 | 689.82K | $43.32M | Add |
| Q2 2026 | 534.77K | $36.02M | Reduce |
| Q3 2026 | 437.03K | $37.71M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DXCM and 13F data
DXCM (DEXCOM INC) is a Health Care company. 31 other funds we track also report a position in DXCM — the largest reported positions include Baillie Gifford & Co (US$1.25B), Castle Hook Partners LP (US$260.7M), Employees Provident Fund Board (US$189.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DXCM
- Baillie Gifford & Co 14.52M sh · $1.25B · Q3 2026
- Castle Hook Partners LP 3.87M sh · $260.67M · Q2 2026
- Employees Provident Fund Board 2.19M sh · $188.98M · Q3 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held DXCM?
Parkman Healthcare Partners LLC has disclosed DXCM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Parkman Healthcare Partners LLC's current position in DXCM?
As of Q3 2026, Parkman Healthcare Partners LLC holds 437.03K shares of DXCM (DEXCOM INC), valued at $37.71M, representing 3.40% of its reported portfolio and ranking #5.
Has Parkman Healthcare Partners LLC been buying or selling DXCM?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in DXCM. The position peaked in Q1 2026 at 689.82K shares.
Which other funds hold DXCM?
Other major institutional holders of DXCM include Baillie Gifford & Co, Castle Hook Partners LP, Employees Provident Fund Board, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.